参考文献/References:
[1] Ahmad S.Platinum-DNA interactions and subsequent cellular processes controlling sensitivity to anticancer platinum complexes[J],Chem Biodivers,2010,7(3):543-566.
[2] Ren F,Chen R,Wang Y,et al.Paclitaxel-loaded poly(n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer[J].Pharm Res,2011,28(4):897-906.
[3] Cao W,Shiverick K,Namiki K,et al.Docetaxel and bortezomib downregulate Bcl-2 and sensitize PC-3-Bel-2 expressing prostate cancer cells to irradiation[J].World J Urol,2008,26(5):509-516.
[4] Yoshida D,Ebara T,Sato Y,et al.Interaction of radiation and pemetrexed on a human malignant mesothlioma cell line in vitro[J].Anticancer Res,2011,31(9):2847-2851.
[5] Morgan MA,Parsels LA,Maybaum J,et al.Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy:a review[J].Clin Cancer Res,2008,14(21):6744-6750.
[6] Murphy JD, Lucas DR,Somnay YR,et al.Gemcitabine-mediated radiosensitization of human soft tissue sarcoma[J].Transl Oncol,2008,1(1):50-56.
[7] El Shafie RA,Habermehl D,Rieken S,et al.In vitro evaluation of photon and raster-scanned carbon ion radiotherapy in combination with gemcitabine in pancreatic cancer cell lines[J].J Radiat Res,2013,54 Suppl 1:S1113-1119.
[8] Yasui H,Ogura A,Asanuma T,et al.Inhibition of HIF-1alpha by the anticancer drug TAS106.enhances X-ray-induced apoptosis in vitro and in vivo[J].Br J Cancer,2008,99(9):1442-1452.
[9] Illum H.Irinotecan and radiosensitization in rectal cancer[J].Anticancer Drugs,2011,22(4):324-329.
[10] Nam C,Doi K,Nakayaam H.Etoposide induces G2/M arrest and apoptosis in neural progenitor cells via DNA damage and all ATM/p53-related pathway[J].Histol Histopathol,2010,25(4):485-493.
[11] Griffin S,Walker S,Sculpher M,et al.Cetuximab plus radiotherapy for the treatment of locally advanced squamous cell carcinoma of the head and neck[J].Health Technol Assess,2009,13 Suppl 1:S49-54.
[12] Stagno F,Vigneri P,Del Fabro V,et al.Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias[J].Acta Oncol,2010,49(1):109-110.
[13] Bonner JA,Harari PM,Giralt J,et al.Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer:5-year survival data from a phase 3 randomised trial,and relation between cetuximab-induced rash and survival[J].Lancet Oncol,2010,11(1):21-28.
[14] Sato Y,Ebara T,Sunaga N,et al.Interaction of radiation and gefitinib on a human lung cancer cell line with mutant EGFR gene in vitro[J].Anticancer Res,2012,32(11):4877-4881.
[15] Rao K,Kalapurakal S,Chalasani P,et al.A phase Ⅱ study of intra-arterial cisplatin with concurrent radiation and erlotinib for locally advanced head and neck cancer[J].Cancer Chemother Pharmacol,2013,72(3):545-552.
[16] Visentin M,Biason P,Toffoli G.Drug interactions among the epidermal growth factor receptor inhibitors,other biologies and cytotoxic agents[J].Pharmacol Ther,2010,128(1):82-90.
[17] 李英杰,于长海,张文,等.COX-2与LRP在非小细胞肺癌中的表达与肺癌预后的关系[J].临床肺科杂志,2010,15(12):1707-1709.
[18] Inoue T,Anai S,Onishi S,et al.Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model[J].BMC Urol,2013,13:1.
[19] Koontz BF,Miles EF,Rubio MA,et al.Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck:two case studies[J].Head Neck,2008,30(2):262-266.
[20] Viswanathan AN,Lee H,Berkowitz R,et al.A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial cancer[J].Gynecol Oncol,2014,132(1):55-60.
[21] Harada H,Itasaka S,Zhu Y,et al.Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy[J].Br J Cancer,2009,100(5):747-757.
[22] Tamatani T,Takamaru N,Hara K,et al.Bortezomib-enhanced radiosensitization through the suppression of radiation-induced nuclear factor-κB activity in human oral cancer cells[J].Int J Oncol,2013,42(3):935-944.
[23] Isebaert SF,Swinnen JV,McBride WH,et al.Insulin-like growth factor-type 1 receptor inhibitor NVP-AEW541 enhances radiosensitivity of PTEN wild-type but not PTEN-deficient human prostate cancer cells[J].Int J Radiat Oncol Biol Phys,2011,81(1):239-247.
[24] 吴冬梅,杨荣宁.莪术油对鼻咽癌CNE-2细胞的调亡及放疗增敏机制的影响[J].肿瘤防治研究,2008,11(35):778-782.
[25] 曹远东,孙新臣,成红艳,等.汉防己甲素配合放射线增敏治疗鼻咽癌的临床研究[J].东南大学学报,2008,27(2):106-109.
[26] 刘少龙,罗辉,谢淑华.三氧化二砷对胃癌细胞放射增敏作用的研究[J].江西医学院学报,2009,49(2):47-50.
[27] 汤继英,潘东风,石小燕,等.三氧化二砷对人宫颈癌细胞的放射增敏作用[J].郧阳医学院学报,2008,27(2):109-111.
[28] 谢良喜,李德锐,林英城,等.三氧化二砷对鼻咽癌离体细胞的放射增敏作用[J].中华放射医学与防护杂志,2004,24(3):240-242.
[29] 杨百霞,杨曦,朱琪伟,等.盐酸小檗碱对乏氧食管癌细胞的放射增敏作用[J].中华放射医学与防护杂志,2013,33(5):484488.
[30] 王振华,师国珍,张宁,等.去甲斑蝥素对肺癌A549细胞株体外放射增敏作用[J].中国实用医刊,2009,36(24):8-10.
[31] 封阳,周媛媛,杨巍,等.青蒿素联合60Coγ射线对Hela和SiHa细胞所致DNA损伤的研究[J].苏州大学学报:医学版,2011,31(1):2-5.
[32] 陈遐林,曹建平,纪蓉,等.二氢青蒿素对人宫颈癌HeLa细胞放射增敏作用的研究[J].中华放射医学与防护杂志,2009,29(4):360-363.
[33] 郭素敏,宗会迁,孙超英,等.中药扶正联合放射治疗肺癌的临床研究[J].河北医药,2008,30(8):1164-1165.
[34] 刘军叶,郭鹞,郭国祯.Bcl-2基因特异性小干涉RNA增强食管癌细胞辐射敏感性的实验研究[J].国际放射医学核医学杂志,2006,30(2):110-113.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]李景涛,邓垒,张文珏,等.广泛期小细胞肺癌胸部IMRT后发生放射性肺炎的危险因素分析[J].国际放射医学核医学杂志,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
Li Jingtao,Deng Lei,Zhang Wenjue,et al.Risk factor analysis for predicting radiation pneumonitis in extensive stage small cell lung cancer patients receiving IMRT thoracic radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
[4]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[5]刘佳,高刚,朴春南,等.调节肿瘤放射敏感性的miRNAs研究进展[J].国际放射医学核医学杂志,2016,40(2):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
Liu Jia,Gao Gang,Piao Chunnan,et al.Progress of microRNAs in regulating tumor radiation sensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
[6]赵德云,李百龙.植物提取物防治放射性肺损伤的现状与展望[J].国际放射医学核医学杂志,2016,40(3):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
Zhao Deyun,Li Bailong.Protective and therapeutic effects of plant extracts on radiation-induced lung injury:present status and future prospects[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
[7]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[8]邓大平,卢峰,孙洪强,等.颅脑肿瘤放射治疗时射野外器官吸收剂量体模法测量与分析[J].国际放射医学核医学杂志,2016,40(4):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
Deng Daping,Lu Feng,Sun Hongqiang,et al.Test and analysis of out-of-field organ dose in intracranial tumor radiotherapy using phantom[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
[9]任佳忠,李永梅,刘岩,等.99Tcm-MDP骨显像胸部异常放射性摄取的原因分析[J].国际放射医学核医学杂志,2016,40(6):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
Jiazhong,Li Yongmei,Liu Yan,et al.Reasons for the abnormal 99Tcm-MDP uptake in the thoracic tissue on bone scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
[10]马彦云,张辉.磁共振体素内不相干运动扩散加权成像的原理及应用进展[J].国际放射医学核医学杂志,2016,40(6):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
Ma Yanyun,Zhang Hui.The basic principle and application progress of intravoxel incoherent motion imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
[11]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[12]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[13]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[14]贾立立,孟粹达,刘晓冬,等.头颈部肿瘤放疗中转化医学相关机制的研究进展[J].国际放射医学核医学杂志,2015,39(3):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
Jia Lili,Meng Cuida,Liu Xiaodong,et al.Development in translational medicine-related mechanisms of radiotherapy for head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
[15]李继涛,何明远,袁德晓,等.p53调控的能量代谢对辐射效应的影响[J].国际放射医学核医学杂志,2012,36(6):380.[doi:10.3760/cma.j.issn.1673-4114.2012.06.014]
LI Ji-tao,HE Ming-yuan,YUAN De-xiao,et al.Influence of p53-regulated energy metabolism in radiation effects[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(6):380.[doi:10.3760/cma.j.issn.1673-4114.2012.06.014]
[16]万丹丹,王宏,温镭,等.放射治疗热增敏作用研究进展[J].国际放射医学核医学杂志,2012,36(3):160.[doi:10.3760/cma.j.issn.1673-4114.2012.03.010]
WAN Dan-dan,WANG Hong,WEN Lei,et al.Progress on thermal sensitization of radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(6):160.[doi:10.3760/cma.j.issn.1673-4114.2012.03.010]
[17]何垠波,周莉,徐庆丰,等.网络管理对肿瘤放疗流程的优化[J].国际放射医学核医学杂志,2012,36(3):182.[doi:10.3760/cma.j.issn.1673-4114.2012.03.016]
HE Yin-bo,ZHOU Li,XU Qing-feng,et al.Optimization of the radiotherapy procedure using network management[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(6):182.[doi:10.3760/cma.j.issn.1673-4114.2012.03.016]
[18]郭睿,李彪.早期生长反应基因1启动子介导肿瘤基因-放疗的研究进展[J].国际放射医学核医学杂志,2010,34(4):206.[doi:10.3760/cma.j.issn.1673-4114.2010.04.004]
GUO Rui,LI Biao.The progress of tumor gene-radiotherapy induced by Egr-1 promoter[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(6):206.[doi:10.3760/cma.j.issn.1673-4114.2010.04.004]
[19]陈娜,涂彧,张旭光.纳米粒子在协同光动力放射治疗中的作用[J].国际放射医学核医学杂志,2010,34(5):318.[doi:10.3760/cma.j.issn.1673-4114.2010.05.018]
CHEN Na,TU Yu,ZHANG Xu-guang.The synergistic effect of nanoparticles in photodynamic therapy and radiation therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(6):318.[doi:10.3760/cma.j.issn.1673-4114.2010.05.018]
[20]宋建波,李思进.放射性心脏损伤临床研究进展[J].国际放射医学核医学杂志,2011,35(2):117.[doi:10.3760/cma.j.issn.1673-4114.2011.02.013]
SONG Jian-bo,LI Si-jin.Advance in clinical research of radiation-induced heart disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(6):117.[doi:10.3760/cma.j.issn.1673-4114.2011.02.013]